Zanubrutinib Linked to Lower Heart Complications Than Chemoimmunotherapy in Leukemia Study
A retrospective cohort study found zanubrutinib was associated with reduced cardiotoxicity and lower rates of atrial fibrillation compared with chemoimmunotherapy ...




















